Hepatitis C testing, infection, and linkage to care among racial and ethnic minorities in the United States, 2009-2010

American Journal of Public Health

Volumn 103, Issue 1, 2013, Pages 112-119

  Tohme, Rania A ^a   Xing, Jian ^a   Liao, Youlian ^a   Holmberg, Scott D ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; ETHNIC GROUP; ETHNOLOGY; FEMALE; HEALTH CARE DELIVERY; HEALTH CARE DISPARITY; HEALTH SURVEY; HEPATITIS C; HUMAN; INTERVIEW; MALE; MIDDLE AGED; MINORITY GROUP; PREVALENCE; QUESTIONNAIRE; RISK FACTOR; SOCIOECONOMICS; UNITED STATES;

ADOLESCENT; ADULT; AGED; ETHNIC GROUPS; FEMALE; HEALTH SERVICES ACCESSIBILITY; HEALTH SURVEYS; HEALTHCARE DISPARITIES; HEPATITIS C; HUMANS; INTERVIEWS AS TOPIC; MALE; MIDDLE AGED; MINORITY GROUPS; PREVALENCE; QUESTIONNAIRES; RISK FACTORS; SOCIOECONOMIC FACTORS; UNITED STATES; YOUNG ADULT;

EID: 84872521034     PISSN: 00900036     EISSN: 15410048     Source Type: Journal    
DOI: 10.2105/AJPH.2012.300858     Document Type: Review

References (31)

1. Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med. 2006;144(10):705-714. (Pubitemid 46780630)
2. Kim WR. The burden of hepatitis C in the US. Hepatology. 2002;36(5, suppl 1):S30-S34.
3. McQuillan GM, Kruszon-Moran D, Kottiri BJ, Curtin LR, Lucas JW, Kington RS. Racial and ethnic differences in the seroprevalence of 6 infectious diseases in the United States: data from NHANES III, 1988-1994. Am J Public Health. 2004;94(11):1952-1958. (Pubitemid 39434829)
4. Flores YN, Yee HF, Leng M, et al. Risk factors for chronic liver disease in Blacks, Mexican Americans, and Whites in the United States: results from NHANES IV, 1999-2004. Am J Gastroenterol. 2008;103(9):2231-2238.
5. Hwang JP, Mohseni M, Gor BJ, Wen S, Guerrero H, Vierling JM. Hepatitis B and hepatitis C prevalence and treatment referral among Asian Americans undergoing community-based hepatitis screening. Am J Public Health. 2010;100(suppl 1):S118-S124.
6. Cheng JT, Hsien C, Sun HJ, Tong MJ. The emerging importance of chronic hepatitis C infection in Asian Americans. Am J Gastroenterol. 2006;101(12):2737-2743. (Pubitemid 44902645)
7. Nguyen MH, Keeffe EB. Chronic hepatitis B and hepatitis C in Asian Americans. Rev Gastroenterol Disord. 2003;3(3):125-134. (Pubitemid 37098671)
8. McMahon BJ, Hennessy TW, Christensen C, et al. Epidemiology and risk factors for hepatitis C in Alaska Natives. Hepatology. 2004;39(2):325-332. (Pubitemid 38222173)
9. Dintsios CM, Haverkamp A, Wiegand J, et al. Economic evaluation of early monotherapy versus delayed monotherapy or combination therapy in patients with acute hepatitis C in Germany. Eur J Gastroenterol Hepatol. 2010;22(3):278-288.
10. Corey KE, Mendez-Navarro J, Gorospe EC, Zheng H, Chung RT. Early treatment improves outcomes in acute hepatitis C virus infection: a meta-analysis. J Viral Hepat. 2010;17(3):201-207.
11. Wong JB, McQuillan GM, McHutchinson JG, Poynard T. Estimating future hepatitis C morbidity, mortality and costs in the United States. Am J Public Health. 2000;90(10):1562-1569.
12. Commission on Social Determinants of Health. Closing the gap in a Generation: Health Equity Through Action on the Social Determinants of Health. Final Report of the Commission of Social Determinants of Health. Geneva, Switzerland: World Health Organization; 2008.
13. Rodríguez-Torres M. Latinos and chronic hepatitis C: a singular population. Clin Gastroenterol Hepatol. 2008;6(5):484-490. (Pubitemid 351609457)
14. Liao Y, Bang D, Cosgrove S, et al. Surveillance of health status in minority communities-Racial and Ethnic Approaches to Community Health Across the U.S. (REACH U.S) Risk Factor Survey, United States, 2009. MMWR Surveill Summ. 2011;60(6):1-44.
15. Khokhar OS, Lewis JH. Reasons why patients infected with chronic hepatitis C virus choose to defer treatment: do they alter their decision with time? Dig Dis Sci. 2007;52(5):1168-1176. (Pubitemid 46626189)
16. Kanwal F, Hoang T, Spiegel BMR, et al. Predictors of treatment in patients with chronic hepatitis C infection-Role of patient versus nonpatient factors. Hepatology. 2007;46(6):1741-1749.
17. Stepanova M, Kanwal F, El-Serag HB, Younossi ZM. Insurance status and treatment candidacy of hepatitis C patients: analysis of population-based data from the United States. Hepatology. 2011;53(3):737-745.
18. Trooskin SB, Navarro VJ, Winn RJ, et al. Hepatitis C risk assessment, testing and referral for treatment in urban primary care: role of race and ethnicity. World J Gastroenterol. 2007;13(7):1074-1078. (Pubitemid 46511009)
19. Centers for Disease Control and Prevention. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR Recomm Rep. 1998;47(RR-19):1-39.
20. Centers for Disease Control and Prevention. Health, United States, 2006: With chartbook on trends in the health of Americans. Hyattsville, MD: National Center for Health Statistics; 2006. Available at: http://www.cdc.gov/nchs/data/ hus/hus06.pdf. Accessed June 28, 2011.
21. US Census Bureau. US interim projections by age, sex, race and Hispanic origin: 2000-2050. Available at: http://www.census.gov/population/www/ projections/usinterimproj. Accessed June 28, 2011.
22. Shehab TM, Orrego M, Chunduri R, Lok ASF. Identification and management of hepatitis C patients in primary care clinics. Am J Gastroenterol. 2003;98(3): 639-644. (Pubitemid 36348538)
23. Navarro VJ, St Louis TE, Bell BP. Identification of patients with hepatitis C virus infection in New Haven County primary care practices. J Clin Gastroenterol. 2003;36(5):431-435. (Pubitemid 36459142)
24. Cheung RC, Currie S, Shen H, et al. Chronic hepatitis C in Latinos: natural history, treatment eligibility, acceptance, and outcomes. Am J Gastroenterol. 2005;100 (10):2186-2193.
25. Rousseau CM, Ioannou GN, Todd-Stenberg JA, et al. Racial differences in the evaluation and treatment of hepatitis C among veterans: a retrospective cohort study. Am J Public Health. 2008;98(5):846-852. (Pubitemid 351671578)
26. Bini EJ, Brau N, Currie S, et al. Prospective multicenter study of eligibility for antiviral therapy among 4,084 U.S. veterans with chronic hepatitis C virus infection. Am J Gastroenterol. 2005;100(8):1772-1779. (Pubitemid 41648433)
27. Giordano C, Druyts EF, Garber G, Cooper C. Evaluation of immigration status, race and language barriers on chronic hepatitis C virus infection management and treatment outcomes. Eur J Gastroenterol Hepatol. 2009;21(9):963-968.
28. Borum ML, Igiehon E, Shafa S, Khokhar OS, Lewis JH. African Americans may differ in their reasons for declining hepatitis C therapy compared to non-African Americans. Dig Dis Sci. 2009;54(7):1604-1605.
29. Melia MT, Muir AJ, McCone J, et al. Racial differences in hepatitis C treatment eligibility. Hepatology. 2011;54(1):70-78.
30. Rein DB, Wittenborn JS, Weinbaum CM, Sabin M, Smith BD, Lesesne SB. Forecasting the morbidity and mortality associated with prevalent cases of pre-cirrhotic hepatitis C in the United States. Dig Liver Dis. 2011;43 (1):66-72.
31. Patient Protection and Affordable Care Act, Pub. L. No. 111-148, § 3502, 124 Stat. 119, 124 (2010).